These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 26478934)
1. Retraction notice to “Memantine enhances the inhibitory effects of naltrexone on ethanol consumption” [Eur.J.Pharmacol.584(2–3) (2008)352–356]. Eur J Pharmacol; 2015 Aug; 761():424. PubMed ID: 26478934 [No Abstract] [Full Text] [Related]
2. Memantine enhances the inhibitory effects of naltrexone on ethanol consumption. Kuzmin A; Stenback T; Liljequist S Eur J Pharmacol; 2008 Apr; 584(2-3):352-6. PubMed ID: 18339371 [TBL] [Abstract][Full Text] [Related]
3. Retraction notice to "MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities" [Eur. J. Pharmacol. 453 (2002) 239-244]. Eur J Pharmacol; 2006 Dec; 553(1-3):304. PubMed ID: 17176514 [No Abstract] [Full Text] [Related]
4. Retraction notice to kinase inhibitors and airway inflammation [Eur. J. Pharmacol 533/1-3 (2006) 118 – 132 of kinase inhibitors and airway inflammation]. Eur J Pharmacol; 2012 May; 683(1-3):340. PubMed ID: 22679637 [No Abstract] [Full Text] [Related]
5. Retraction notice to “PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell lines” [Eur. J. Pharmacol. 714(1–3) (2013) 379–387]. Eur J Pharmacol; 2014 Apr; 728():190. PubMed ID: 24795989 [No Abstract] [Full Text] [Related]
6. Retraction notice to "Introduction of antisense oligonucleotides to Heat Shock Protein 47 prevents pulmonary fibrosis in lipopolysaccharide-induced pneumopathy of the rat" [Eur. J. Pharmacol. 564/1-3 (2007) 174-180]. Hagiwara S; Iwasaka H; Matsumoto S; Noguchi T Eur J Pharmacol; 2016 Dec; 792():80. PubMed ID: 27916230 [No Abstract] [Full Text] [Related]
7. Retraction notice to “Dual ACE-inhibition and angiotensin IIAT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. Eur J Pharmacol; 2015 Aug; 761():423. PubMed ID: 26331164 [No Abstract] [Full Text] [Related]
8. Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30]. Eur J Pharmacol; 2015 Aug; 761():423. PubMed ID: 26478933 [No Abstract] [Full Text] [Related]
9. Notice of Retraction: Tripathy S, Chapman JD, Han CY, Hogarth CA, Arnold SLM, Onken J, Kent T, Goodlett DR, and Isoherranen N (2016) Mol Pharmacol; 2020 Feb; 97(2):61. PubMed ID: 31911429 [No Abstract] [Full Text] [Related]
10. Notice of Retraction: 'A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway' (Br J Pharmacol 135; 589-599; 2002). Br J Pharmacol; 2009 Mar; 156(5):868. PubMed ID: 19338575 [No Abstract] [Full Text] [Related]
11. Effects of the non-competitive NMDA receptor antagonist memantine on the volitional consumption of ethanol by alcohol-preferring rats. Malpass GE; Williams HL; McMillen BA Basic Clin Pharmacol Toxicol; 2010 May; 106(5):435-44. PubMed ID: 20210793 [TBL] [Abstract][Full Text] [Related]
12. Notice of Retraction: 'Liver delivery of NO by NCX-1000 protects against acute liver failure and mitochondrial dysfunction induced by APAP in mice' (Br J Pharmacol 143; 33-42; 2004). Br J Pharmacol; 2009 Mar; 156(5):868. PubMed ID: 19338574 [No Abstract] [Full Text] [Related]